Tuğba Subaş

Dr. Tuğba Subaş

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2023 in Clinical and Experimental Health Sciences
Verified
Journal Article
Open access
PDF file
İGİÇİM GÖKKAYA
İÇİM GÖKKAYA
GRGülin Renda
Gülin Renda
TSTuğba Subaş
Tuğba Subaş
UÖUfuk Özgen
Ufuk Özgen
Objective: Plants have been used to treat ailments since the dawn of humanity. The use of medicinal plants for various purposes such as preventing diseases, treating diseases and supporting medical treatment is increasing day by day. On the other hand, medicinal plants are important sources of raw materials for the pharmaceutical industry. It has been demonstrated that Peganum harmala L. and the phytochemicals it contains have a wide variety of pharmacological activities. P. harmala and its active ingredients can be an important resource for the pharmaceutical industry. In this review, the phytochemistry, pharmacological effects, clinical studies, and toxicity of P. harmala are discussed under the current information. Methods: Studies on P. harmala were searched using Pubmed, Scopus, Science Direct databases, and Google Scholar search engine. As a result of the searches, 96 articles were included in the study. Results: The main group of secondary metabolites responsible for the biological activities of P. harmala is alkaloids. The plant and its isolated secondary plant compounds have been shown to have many pharmacological actions, counting antiamnestic, anticancer, antidepressant, antiinflammatory, cardiovascular, gastroprotective, hepatoprotective, nephroprotective, and vasodilator activities. Studies evaluating the plant's clinical effects have been carried out in recent years. However, it has been recorded in the literature that the use of P. harmala causes poisoning with symptoms such as neurosensory symptoms, visual hallucination, bradycardia, hypotension, agitation, tremor, ataxia, and vomiting. Conclusion: Considering the pharmacological effects, the number of studies on the efficacy and safety of P. harmala and its secondary metabolites should be increased.

1 January 2024 in Ankara Universitesi Eczacilik Fakultesi Dergisi
Verified
Journal Article
Open access
PDF file
TSTuğba Subaş
Tuğba Subaş
UÖUfuk Özgen
Ufuk Özgen
İGİÇİM GÖKKAYA
İÇİM GÖKKAYA
GRGülin Renda
Gülin Renda
Objective: Petroselinum crispum (Mill.) Fuss is a bright green biennial medicinal and aromatic herb that grows almost all over the world. Today, it is one of the most commonly used culinary herbs. In addition to its use as food, it has been shown to possess broad pharmacological activities in several in vivo and in vitro studies. This study aimed to comprehensively summarize the current studies on the traditional use, phytochemical composition, pharmacological activities, clinical studies, toxicity, and drug interactions of parsley. Result and Discussion: According to the literature data, parsley is used as a diuretic, carminative, emmenagogue and for the prevention and treatment of kidney stone formation, the treatment of conditions such as urinary tract infections and stomach disorders. Its phytochemical composition consists of flavonoids, coumarins, phenolic compounds, organic acids, carotenoids, vitamins, minerals, fixed oil, essential oil, and other compounds. Studies on P. crispum have shown that it has a wide range of pharmacological activities, including antioxidant, antibacterial, antifungal, antidiabetic, antihypertensive, antiplatelet, analgesic, antiinflammatory, antihepatotoxic, antinephrotoxic, anticancer, antiurolithiatic, wound healing, antiobesity, estrogenic and neuroprotective effects. This review comprehensively summarizes the scientific data of the last ten years (2013-2023) on P. crispum.

28 April 2025 in Plant Foods for Human Nutrition
Verified
Journal Article
Open access
PDF file
TSTuğba Subaş
Tuğba Subaş
MBMerve Badem
Merve Badem
ŞKŞeyda Kanbolat
Şeyda Kanbolat
UÖUfuk Özgen
Ufuk Özgen
SSSila Ozlem Sener
Sila Ozlem Sener
MŞMevlüde İlKnur Şeker
Mevlüde İlKnur Şeker
Trachystemon orientalis (L.) D.Don is a perennial herb extensively utilized for culinary purposes and the treatment of numerous ailments. Hyperlipidemia is a significant risk factor for atherosclerosis, diabetes, obesity, and coronary heart disease. The inhibition of pancreatic lipase (PL) and cholesterol esterase (CE) aims to mitigate problems associated with lipid metabolism disorders by decreasing hyperlipidemia. In this context, enhancing antioxidant capability is an additional objective. This study assessed the PL and CE inhibitory actions of extracts and compounds from the aerial parts of T. orientalis, utilizing ferric reducing antioxidant power (FRAP) and cupric-reducing antioxidant capacity (CUPRAC) assays to measure antioxidant capabilities. Rosmarinic acid, a combination of rosmarinic acid and danshensu (phenolic acids), and β-sitosterol (phytosterol) were isolated. β-sitosterol (IC50: 41.698 ± 1.982 µg/mL, 14.249 ± 1.209 µg/mL, respectively) followed by rosmarinic acid (IC50: 48.213 ± 2.490 µg/mL, 21.941 ± 3.785 µg/mL, respectively) demonstrated significant inhibitory effects on PL and CE. Additionally, rosmarinic acid (FRAP: 1274.400 ± 1.633 µM TEAC, CUPRAC: 1801.389 ± 5.500 µM TEAC) and its combination with danshensu (FRAP: 1405.067 ± 4.491, CUPRAC: 2174.167 ± 9.647 µM TEAC) exhibited high antioxidant activity. The ethyl acetate subextract (TOE) from which rosmarinic acid was isolated showed considerable enzyme inhibitory (IC50: 47.577 ± 0.931 µg/mL, 12.443 ± 1.233 µg/mL, for PL and CE inhibition, respectively) and antioxidant activity (FRAP: 1770.021 ± 4.583, CUPRAC: 2189.167 ± 5.401 µM TEAC). T. orientalis has been identified as a promising natural resource for the management of lipid metabolism-related disorders and for enhancing antioxidant activity.

6 February 2026 in International Journal of Food Sciences and Nutrition
Verified
Journal Article
Closed access
TSTuğba Subaş
Tuğba Subaş
SCsumeyra cetinkaya
sumeyra cetinkaya
SSSeda Sirin
Seda Sirin
TBTugce Baser
Tugce Baser
ISIpek Suntar
Ipek Suntar
Obesity and its associated metabolic disorders, including type 2 diabetes mellitus, non-alcoholic fatty liver disease, and cardiovascular complications, represent a major global health burden. A key pathogenic mechanism linking these conditions is the overactivation of the NLRP3 inflammasome, which triggers caspase-1 activation and promotes proinflammatory cytokine release (e.g., IL-1β and IL-18), driving adipose tissue dysfunction, insulin resistance, and systemic inflammation. Emerging evidence highlights dietary polyphenols as natural modulators of NLRP3 activity attenuating inflammasome activation by regulating NF-κB signalling, reducing oxidative stress and restoring autophagy. Complementary in silico approaches (e.g., molecular docking, molecular dynamics simulations, network pharmacology) provide mechanistic insights into polyphenol-inflammasome interactions. This review summarises current evidence on the NLRP3's role in obesity-related disorders and discusses the therapeutic potential of dietary polyphenols, underscoring directions for translational and multidisciplinary research.

28 February 2024 in Turkish Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
AKAyşe Nur Koz
Ayşe Nur Koz
TSTuğba Subaş
Tuğba Subaş
MBMerve Badem
Merve Badem
ŞKŞeyda Kanbolat
Şeyda Kanbolat
UÖUfuk Özgen
Ufuk Özgen
Ihsan ÇalışIhsan Çalış
Ihsan Çalış
Trachystemon orientalis D.Don, an edible plant, is widely used in folk medicine. This study aimed to investigate the antioxidant and lipase inhibitory activities of the extracts and isolated compounds from the underground parts of T. orientalis (TOU). Isolation studies were carried out on the subextracts (the chloroform, ethyl acetate and remaining aqueous) prepared from the methanol extract of TOU using various chromatographic methods, and the structures of the purified compounds were determined by 1D-NMR, 2D-NMR, and mass spectroscopy techniques. To determine antioxidant activity, ferric-reducing antioxidant power (FRAP) and Cu(II) ion-reducing antioxidant capacity (CUPRAC) assays were performed. Lipase inhibitory activity was determined using an in vitro spectrophotometric method. In the isolation studies, rosmarinic acid (1) was isolated from the ethyl acetate subextract and danshensu (2), globoidnan B (3), and rabdosiin (4) were isolated from the remaining aqueous subextract. These compounds were isolated from TOU for the first time. The ethyl acetate subextract had higher activity than the other extracts in the FRAP and CUPRAC assays (794.818 ± 8.999, 583.06 ± 5.882 μM Trolox equivalents (TE)/g), respectively] and rosmarinic acid exhibited the highest activity [1260.273 ± 4.499, 608.250 ± 1.195 μM TE/g, respectively). Lipase enzyme inhibitory studies showed that the remaining aqueous and ethyl acetate subextracts had significant inhibitory activity [half maximal inhibitory concentration (IC50 = 38.131 ± 0.720, 38.841 ± 1.359 μg/mL respectively). All isolated compounds inhibited lipase, and rosmarinic acid was the most effective (IC50 = 49.421 ± 1.448 μg/mL). According to the results of this study, T. orientalis and its isolated compounds may be a promising natural therapeutic agent for the treatment of obesity via its high antioxidant capacity and lipase inhibitory activity.

20 November 2023 in European Journal of Therapeutics
Verified
Journal Article
Open access
PDF file
İGİÇİM GÖKKAYA
İÇİM GÖKKAYA
TSTuğba Subaş
Tuğba Subaş
GRGülin Renda
Gülin Renda
SŞSevim Şahin
Sevim Şahin
UÖUfuk Özgen
Ufuk Özgen
ACAli Cansu
Ali Cansu
Objectives: The use of herbal products/dietary supplements (HP/DS) in the pediatric population is increasing day by day. The interaction of HP/DSs with drugs with a narrow therapeutic index such as phenytoin, phenobarbital, and valproic acid, may cause problems in treatment. In this respect, it is very important to determine the use of HP/DS in children with neurological diseases and/or complaints. In this study, it was aimed to determine the use of HP/DS and the factors affecting the use of these products in individuals with a neurological complaint and/or disease who applied to the pediatric neurology outpatient clinic. Methods: Parents were questioned face-to-face as part of the descriptive questionnaire research. 174 questionnaires with appropriate data quality were included in the study. The statistical software tool SPSS 23.0 was used to analyze the data. Results: 44.6% of the parents stated that they gave HP/DS to their children. The findings of the analysis showed that kids whose parents use HP/DS are more likely to utilize these items themselves (p<0.001). The most commonly used products are linden (70.1%), bee products (26.0%), carob (18.2%), chamomile (13.0%), and lemon (13.0%). It has been determined that the reasons for parents to have their children use HP/DS are to strengthen the immune system (51.9%), improve general health status (40.3%), and supplement normal nutrition (27.3%), respectively. Conclusions: This study revealed a high frequency of HP/DS use in children with pediatric neurological diseases/complaints in Türkiye. The frequency of HP/DS use was higher in children whose parents tended to consume HP/DS. Considering the high use of these products, healthcare professionals need to inform parents to prevent adverse effects caused by HP/DS.